Contenuto
Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »PRIN - Programmi di ricerca di Rilevante Interesse Nazionale»Programma di ricercaINIZIO_TESTO_DA_INDICIZZARE
PROGRAMMA DI RICERCA 2005
italiano - english
Unità di Ricerca
- Seconda Università degli Studi di NAPOLI
BIOCHIMICA E BIOFISICA "FRANCESCO CEDRANGOLO"
CASERTA(CE) - Università degli Studi "Magna Graecia" di CATANZARO
MEDICINA SPERIMENTALE E CLINICA
CATANZARO(CZ) - Università degli Studi di ROMA "La Sapienza"
SCIENZE BIOCHIMICHE
ROMA(RM) - Università degli Studi di NAPOLI "Federico II"
BIOCHIMICA E BIOTECNOLOGIE MEDICHE
NAPOLI(NA) - Seconda Università degli Studi di NAPOLI
BIOCHIMICA E BIOFISICA "FRANCESCO CEDRANGOLO"
CASERTA(CE)
Programmi di ricerca simili:
- 1 - Apoptosi e terapia del cancro: caratterizzazione di nuovi meccanismi e nuove molecole modulatrici dell'apoptosi
- 2 - Medulloblastoma: studio delle vie molecolari di sviluppo e progressione tumorale allo scopo di identificare approcci terapeutici innovativi
- 3 - STUDIO CON APPROCCI DI GENOMICA E PROTEOMICA DELL'ESPRESSIONE, DELL'ATTIVITA' E COMPARTIMENTALIZZAZIONE INTRACELLULARE DI PROTEINE COINVOLTE NEL SIGNALLING IN CELLULE TUMORALI UMANE ESPOSTE O NON AD AGENTI BIOLOGICI E CITOTOSSICI.
- 4 - STRESS OSSIDATIVO, CANCRO E CRESCITA METASTATICA: RUOLO DELLA REGOLAZIONE REDOX
- 5 - I membri della famiglia del TNF nella modulazione del differenziamento cellulare e dell'attività antitumorale
- 6 - MECCANISMI REDOX DI SEGNALAZIONE CELLULARE COINVOLTI NELLA GENESI DI MALATTIE ASSOCIATE A STRESS OSSIDATIVO
- 7 - Progressione dei carcinomi della ghiandola mammaria e della prostata: nuovi meccanismi ormonali e approcci terapeutici.
- 8 - ANALISI DEI MECCANISMI DI SOPRAVVIVENZA CELLULARE DI EUCARIOTI MEDIANTE STRATEGIE DI PROTEOMICA
- 9 - Ruolo di recettori di membrana e nucleari nell'interazione funzionale tra segnali estrogenici e di fattori di crescita nei tumori ormono-responsivi.
- 10 - Ruolo delle cellule staminali prostatiche e della stimolazione ipossica nella progressione tumorale.
Classificazione scientifico-disciplinare
- Area scientifico disciplinare: Scienze biologiche
Classificazione brevettuale
- CHEMISTRY; METALLURGY
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
- BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Classificazione geografica
- Regione: Campania
Bibliografia
1) M. Caraglia, A. Abbruzzese, A. Leardi, S. Pepe, A. Budillon, G. Baldassarre, C. Selleri, S. De Lorenzo, A. Fabbrocini, G. Giuberti, G. Vitale, G. Lupoli, A. R. Bianco, and P. Tagliaferri (1999) Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor" Cell Death Differ. 6, 773-780.2) M. Caraglia, P. Tagliaferri, M. Marra, G. Giuberti, A. Budillon, E. Di Gennaro, S. Pepe, G. Vitale, S. Improta, P. F. Tassone, S. Venuta, A. R. Bianco and A. Abbruzzese “EGF activates an inducible survival response via the RAS -> ERK-1/2 pathway to counteract interferon-a-mediated apoptosis in epidermoid cancer cells”. Cell Death Differ., 10 (1), 218-229, 2003
3) Baserga R, et al. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332:F105-F126, 1997
4) Macaulay, V.M. Insulin-like growth factors and cancer. Br. J . Cancer }{i 65: 311-320, 1992.
5) Reiss KP, et al.. The insulin-like growth factor I is required for the proliferation of hemopoietic cells. Oncogene, 7:2243-2248, 1992
6) Frasca F, et al. Insulin receptor isoform A, a newly recognized high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 19:3278-88, 1999
7) Sciacca L, et al. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene, 18:2471-2479, 1999.
1990
18) Riabowol S. et Al., (1988) The catalytic subunit of cAMP-dependent protein kinase induces expression of genes containing cAMP-responsive enhancer elements. Nature, 336, 83-86
19) Sassone-Corsi P. et Al., (1999) Signaling routes to CREM and CREB: plasticity in transcriptional activation. TIBS, Reviews, 24, 281-285
20) Reuse S. et Al., (1990) Regulation of protooncogenes c-fos and c-myc expressions by protein tyrosine kinase, protein kinase C, and cyclic AMP mitogenic pathways in dog primary thyrocytes: a positive and negative control by cyclic AMP on c-myc expression. Exp. Cell Res., 189, 33-40
21) Migliaccio A. et Al., (1998) Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J., 17, 2008-2018
22) Hochstrasser M., (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Current Opinion in Cell Biology, 7, 215-223
23) Hicke L., (1999) Gettin¡| down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends in Cell Biol., 9, 107-112
24) Ciechanover A., (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J., 17, 7151-7160
25) C.R. Woese, et al. (1990) Proc. Natl. Acad. Sci. USA 87, 4576-4579.
26) D.L. Miller & H. Weissbach In "Molecular Mechanisms of Protein Biosynthesis" H. Weissbach & S. Pestka, eds. (1977) Academic Press, New York pp. 323-373.
27) B. Riis, S.I.S. et al. (1990) TIBS 15, 420-424.
28) C. Esposito, M. Marra, G. Giuberti, A. M. D’Alessandro, R. Porta, A. Cozzolino, M. Caraglia, A. Abbruzzese. Tissue transglutaminase ubiquitination is modulated by interferona in human lung cancer cells. Biochemical Journal, 370, 205-212, 2003
29) M. Caraglia, et al. (2000) Eur. J. Biochem. 3919-3936.
30)Abbruzzese, A., et al. (1986) Deoxyhypusine hydroxylase from rat testis: partial purification and characterization. J. Biol. Chem. 261, 3085-3089
31)Abbruzzese, A. Et al. (1988) Deoxyhypusine hydroxylase. Adv. Exp. Med. Biol. 250, 459-466
32)Abbruzzese, A., et al. (1986) Indirect assays for deoxyhypusine hydroxylase using dual-label ratio changes and oxidative release of radioactivity. Anal. Biochem. 154, 664-670
33)Abbruzzese, A. (1988) Developmental pattern for deoxyhypusine hydroxylase in rat brain. J. Neurochem. 50, 695-699
34) Beninati, S., Abbruzzese, A. & Folk, J.E. (1990) High-Performance Liquid chromatographic Method for Determination of Hypusine and Deoxyhypusine. Anal. Biochem. 184, 16-20.
35)Abbruzzese, A., et al. (1991) The active site of deoxyhypusyl hydroxylase: use of catecholpeptides and their component chelator and peptide moieties as molecular probes. Biochem. Biophys. Acta 1077, 159-166
36)M. Caraglia, et al. (1996) Interferon alpha recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells. Biochem. J. 324, 737-741
37) K. Moldave. Eukaryotic protein synthesis. (1985) Ann. Rev. Biochem. 54, 1109-1149.
38) Rattan,S.I.S.,et al. (19887 Biochim. Biophys. Res. Commun. 152, 169-176.
39) Gschwendt, M. Et al. Biochim. Biophys. Res. Commun. 1988, 150, 545-551.
40) R.E. Rhoads (1993) J. Biol. Chem. 266, 3017-3020.
41) R.M. Frederickson & N. Sonenberg (1992) Semin. Cell. Biol. 3, 107-115.
42) J.W.B. Hershey (1991) Ann. Rev. Biochem. 60, 717-755.
43) Thomas, G. and Thomas G. J. Cell. Biol. 1986, 103, 2137-2144.
44) Cavallius J., et al. Exp. Gerontol. 1986, 21, 149-157.
45) Ayala A., Parrado J., Bougria M. and Machado A. J. Biol. Chem. 1996, 271, 23105-23110.
46) N. Sonenberg (1993) Current Opinion Cell Biol. 5, 955-960.
47] Fendrick J.L. and Iglewski W.J. Proc. Natl. Acad. Sci. USA 1989, 86, 554-557.
48) S. Zao-zhong, et al. (1998) Proc. Natl. Acad. Sci. USA 95, 1764-1769.
49) B.T. Edmonds, et al. (1996) J. Cell Sci. 109, 2705-2714.
50) M.V. Kato, H. Sato, M. Nagayoshi, Y. Ikawa. (1997) Blood 90, 1373-1378.
51) M.V. Kato, H. Sato, M. Nagayoshi, Y. Ikawa. (1997) Blood 90, 1373-1378.
52) M.V. Kato (1999) Leuk. Lymphoma 33, 181-186.
53) A. Duttaroy, et al. (1998) Exp. Cell Res. 238, 168-176.
54) E. Chen, et al. (2000) Exp. Cell Res. 259, 140-148.
55) Bachrach U. and Heimer Y.M. The Physiology of Polyamines.
CRC Press, Boca Raton. (1989).
56) Harari P.M. et al. Polyamine
biosynthesis inhibitors combined with systemic
hyperthermia in cancer therapy. Int. J. Radiat Oncol. Biol. Phys.
(1990) 19, 89-96.
56) Agostinelli E., et al. Cytotoxicity of polyamines in Chinese
Hamster Ovary (CHO) Cells in the presence of purified serum
amine oxidase. Life Chemistry Reports (1991) 9, 193-204.
57) Averill-Bates D.A., Agostinelli E., et al.Cytotoxicity and Kinetic Analysis for Purified
Bovine Serum Amine Oxidase in the presence of Spermine in CHO
Cells. Arch. Biochem. Bioph. (1993) 300/1, 75-79.
58) Averill-Bates D.A., Agostinelli E., et al. Aldehyde Dehydrogenase and Cytotoxicity of Purified
Bovine Serum Amine Oxidase and Spermine in Chinese Hamster
Ovary Cells. Biochem. and Cell Biology. (1994) 72, 36-42-Canada.
59) Agostinelli E., et al. Heat Enhancement of Cytotoxicity Induced by Oxidation Products
Of Spermine in Chinese Hamster Ovary Cells. Biochem. Pharm.
(1994) 48, 1181-1186.
60) Agostinelli E. Cytotoxic effect of the products of spermine
enzymatic oxidation on wil-type and multidrug-resistant cultured cells.
Italian Biochem. Society Trans. (1997) 9, 37-40.
61) A. Calcabrini; G. Arancia; M. Marra; P. Crateri; O. Befani; A. Martone; Agostinelli E. (2002). Enzimatic Oxidation Products Of Spermine Induce Greater Cytotoxic Effects On Human Multidrug-Resistant Colon Carcinoma Cells (Lovo) Than On Their Wild-Type Counterparts. International Journal Of Cancer. (Vol. 99(1) Pp. 43-52)



